Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
about
Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial InfectionsUpdate on the Epidemiology and Antibiotic Resistance of Ocular Infections.Ocular penetration of topically applied 1% tigecycline in a rabbit model.In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal EndophthalmitisEffect of acacia honey on cultured rabbit corneal keratocytesAntibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery.Acacia honey accelerates in vitro corneal ulcer wound healing modelMethicillin-Resistant Staphylococcus aureus Ocular Infection in Taiwan: Clinical Features, Genotying, and Antibiotic SusceptibilityInfectious keratitis: secreted bacterial proteins that mediate corneal damage.A European perspective on topical ophthalmic antibiotics: current and evolving options.Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis.Antibiotic susceptibility of staphylococci isolates from patients with chronic conjunctivitis: including associated factors and clinical evaluation.Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis.Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland.Characterization of ocular methicillin-resistant Staphylococcus epidermidis isolates belonging predominantly to clonal complex 2 subcluster II.Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015.The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.Antibiotic susceptibility profiles of ocular and nasal flora in patients undergoing cataract surgery in Taiwan: an observational and cross-sectional study.Pathogens and antibiotic sensitivities in endophthalmitis.Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.Pharmacological treatment for infectious corneal ulcers.Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitisMicrobial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis.Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery.Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.Spectrum of bacterial keratitis at a tertiary eye care centre in India.Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study
P2860
Q26752242-E941928C-C7E1-429C-A627-F461FC9BC6B0Q33691972-72514F45-4DD3-4DEF-8E70-7FAA91759928Q33706051-25E8CE6B-D4FA-48FF-A983-59EDD631654AQ35167160-95F5E8FD-7EC1-4453-BB79-5F0018CB480DQ35178752-DDD170DD-AA36-4E03-B9D3-D190B22679D2Q35617621-E243131A-C8CC-4122-9D50-0541F2D5B509Q36090007-D624482D-D999-4D0B-BBAB-5F95EB3647CCQ36207078-A937D965-3DCC-4387-9B4F-AB56F04F2B33Q36567361-0D911F63-1467-4244-9EFF-5DBE18C052FFQ36867161-65555CC9-5453-4E11-83AC-1725FD0B534DQ37125014-416CE450-9533-43C0-8249-035014D7D55AQ37277669-CDAC3133-DA4D-4E93-B9EF-238058F59FBDQ37706631-B45393AC-10BB-466E-85EE-03DEADA36F2FQ38021408-C0EDF9E5-5305-4954-88DA-BCAE3DAD4205Q38213344-BE1D7163-D61B-423A-B91B-4553A4C533D9Q38856884-92319622-3CD9-45B9-81F8-3F0D6CCEBD62Q39201681-FEA79104-9E6E-4BC8-8981-DF93F0300DC5Q39747466-17A82B77-7066-4F9E-858A-B7321000F195Q40087692-69075462-7C67-4E58-9F97-D89ABDFF5309Q40396060-9AC5AD50-9D8C-43A2-80D6-861F606FFE6FQ41878765-C945ABFE-19D9-4210-846C-5FD06F6CEC06Q42273313-D43A6F62-E903-47AA-B756-1205473D3717Q42729444-B901A343-9FF8-40ED-B22B-82F55BB9BD12Q42940600-55E192FF-964A-4E85-B808-C41C6072F065Q44809886-977A27C9-969E-433D-9C54-892443D11876Q45018865-C01CD004-D52B-4614-BA0A-483C104BBA90Q55631269-A26988D2-568E-4906-A1E3-045A5DAD87CBQ58602018-091E5B14-B5B7-4460-A917-366E9CABC338
P2860
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@en
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@nl
type
label
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@en
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@nl
prefLabel
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@en
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@nl
P1476
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
@en
P2093
Joseph M Blondeau
Marguerite McDonald
P304
P356
10.1016/J.JCRS.2010.06.028
P577
2010-09-01T00:00:00Z